Fremanezumab reduced migraine attacks and depression symptoms in migraine patients with major depressive disorder.

Migraines are debilitating and often chronic conditions that affect millions of people worldwide. Those who suffer from migraines understand the desperate search for effective solutions that provide ...

The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

WHEN a migraine hits, most of us make a beeline for a dark room and hope the painkillers kick in fast. But what if popping ...

Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

As per NHS guidance, you should see a GP if your headache keeps coming back, if painkillers do not help and your headache ...

Brain fog is one of the most common symptoms of migraine. Understand its causes and learn practical tips and strategies for ...

Sensitivity to smell (osmophobia) or smelling things that aren't there (phantosmia) can be another symptom of migraine. An ...

Approval is based on results from the Phase III ASCEND trial, in which patients using the powder achieved freedom from pain ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.